{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:02:28Z","timestamp":1790805748791,"version":"4.1.0"},"reference-count":32,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T00:00:00Z","timestamp":1395619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T00:00:00Z","timestamp":1395619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1111\/jcpt.12157","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T02:04:36Z","timestamp":1395713076000},"page":"411-417","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages"],"prefix":"10.1155","volume":"39","author":[{"given":"K.","family":"Ikawa","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacotherapy; Hiroshima University; Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"First Department of Medicine; Hokkaido University School of Medicine; Sapporo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"First Department of Medicine; Hokkaido University School of Medicine; Sapporo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nishimura","sequence":"additional","affiliation":[{"name":"First Department of Medicine; Hokkaido University School of Medicine; Sapporo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Derendorf","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics; College of Pharmacy; University of Florida; Gainesville FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacotherapy; Hiroshima University; Hiroshima Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2014,3,24]]},"reference":[{"key":"10.1111\/jcpt.12157-BIB0001|jcpt12157-cit-0001","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00003495-200161040-00003","article-title":"Review of macrolides and ketolides: focus on respiratory tract infections","volume":"61","author":"Zhanel","year":"2001","journal-title":"Drugs"},{"key":"10.1111\/jcpt.12157-BIB0002|jcpt12157-cit-0002","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003088-199937050-00003","article-title":"Clinical pharmacokinetics of clarithromycin","volume":"37","author":"Rodvold","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12157-BIB0003|jcpt12157-cit-0003","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2165\/00003088-200544090-00003","article-title":"Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial","volume":"44","author":"Shi","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12157-BIB0004|jcpt12157-cit-0004","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1183\/09031936.94.07071275","article-title":"The levels of clarithromycin and its 14-hydroxy metabolite in the lung","volume":"7","author":"Honeybourne","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1111\/jcpt.12157-BIB0005|jcpt12157-cit-0005","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/AAC.39.2.334","article-title":"Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin","volume":"39","author":"Conte","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0006|jcpt12157-cit-0006","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/AAC.40.7.1617","article-title":"Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects","volume":"40","author":"Conte","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0007|jcpt12157-cit-0007","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/AAC.40.10.2375","article-title":"Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin","volume":"40","author":"Patel","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0008|jcpt12157-cit-0008","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1128\/AAC.41.6.1399","article-title":"Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers","volume":"41","author":"Rodvold","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0009|jcpt12157-cit-0009","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1440-1843.2007.01208.x","article-title":"Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid","volume":"13","author":"Kikuchi","year":"2008","journal-title":"Respirology"},{"key":"10.1111\/jcpt.12157-BIB0010|jcpt12157-cit-0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pupt.2008.11.004","article-title":"Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease","volume":"22","author":"Hasegawa","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1111\/jcpt.12157-BIB0011|jcpt12157-cit-0011","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/47.6.837","article-title":"Lung concentrations of telithromycin after oral dosing","volume":"47","author":"Khair","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/jcpt.12157-BIB0012|jcpt12157-cit-0012","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1128\/AAC.45.11.3104-3108.2001","article-title":"Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647)","volume":"45","author":"Muller-Serieys","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0013|jcpt12157-cit-0013","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.46.3.917-921.2002","article-title":"Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers","volume":"46","author":"Kadota","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0014|jcpt12157-cit-0014","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000088958","article-title":"Intrapulmonary concentrations of telithromycin: clinical implications for respiratory tract infections due to Streptococcus pneumoniae","volume":"51","author":"Ong","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1111\/jcpt.12157-BIB0015|jcpt12157-cit-0015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.pupt.2006.05.006","article-title":"Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses","volume":"20","author":"Kikuchi","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1111\/jcpt.12157-BIB0016|jcpt12157-cit-0016","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/0003088-200948010-00002","article-title":"Ketolides-the modern relatives of macrolides: the pharmacokinetic perspective","volume":"48","author":"Zeitlinger","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12157-BIB0017|jcpt12157-cit-0017","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/AAC.46.2.586-589.2002","article-title":"Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and Monte Carlo simulation","volume":"46","author":"Drusano","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0018|jcpt12157-cit-0018","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1128\/AAC.00736-06","article-title":"Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0019|jcpt12157-cit-0019","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/AAC.01110-07","article-title":"Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0020|jcpt12157-cit-0020","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/AAC.01330-10","article-title":"Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia","volume":"55","author":"Lodise","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0021|jcpt12157-cit-0021","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1128\/AAC.00712-11","article-title":"Penetration of vancomycin into epithelial lining fluid in healthy volunteers","volume":"55","author":"Lodise","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0022|jcpt12157-cit-0022","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit-a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1111\/jcpt.12157-BIB0023|jcpt12157-cit-0023","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/AAC.05354-11","article-title":"Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers","volume":"56","author":"Housman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0024|jcpt12157-cit-0024","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jac\/dkh475","article-title":"Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations","volume":"54","author":"Zhanel","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/jcpt.12157-BIB0025|jcpt12157-cit-0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijid.2008.08.016","article-title":"Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae","volume":"13","author":"Noreddin","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1111\/jcpt.12157-BIB0026|jcpt12157-cit-0026","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2004.12.005","article-title":"Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens","volume":"52","author":"Lodise","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/jcpt.12157-BIB0027|jcpt12157-cit-0027","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/AAC.49.5.1943-1948.2005","article-title":"Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary","volume":"49","author":"Zhanel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12157-BIB0028|jcpt12157-cit-0028","unstructured":"MIC distributions European Committee on Antimicrobial Susceptibility Testing, European Society of Clinical Microbiology and Infectious Diseases http:\/\/mic.eucast.org\/Eucast2\/"},{"key":"10.1111\/jcpt.12157-BIB0029|jcpt12157-cit-0029","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/dkm536","article-title":"Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation","volume":"61","author":"Frei","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/jcpt.12157-BIB0030|jcpt12157-cit-0030","unstructured":"Biaxin Tablets package insert Abbott Laboratories (North Chicago, IL, USA) http:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=aa44552c-3cfe-4111-8aa5-4251aeed9be9"},{"key":"10.1111\/jcpt.12157-BIB0031|jcpt12157-cit-0031","unstructured":"Ketek Tablets package insert Sanofi-Aventis (Bridgewater, NJ, USA) http:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=4471223e-9023-457e-be2e-8e4e0c2d94d1"},{"key":"10.1111\/jcpt.12157-BIB0032|jcpt12157-cit-0032","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/AAC.47.6.1867-1874.2003","article-title":"Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002","volume":"47","author":"Zhanel","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12157","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12157","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12157\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:22Z","timestamp":1671818722000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,24]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12157","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,24]]}}}